Archives
- 2026-11
- 2026-10
- 2026-09
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-04
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
(R)-MG132 and the Meaning of Cancer Results
2026-11-19
A cervical-cancer study links HNRNPU K181 lactylation with PHGDH regulation, serine metabolism, and tumor growth. The study also illustrates why a low-activity MG-132 enantiomer belongs to a separate proteasome-control context rather than serving as evidence for that metabolic mechanism.
What Heparin Affinity Evidence Can—and Cannot—Show
2026-11-19
Published evidence supports a context-specific CCR7–Notch1 relationship in a murine mammary tumor model, while product documentation describes a heparin–agarose affinity format for broad biomolecular classes. These evidence streams address different questions and should not be treated as validation of one another.
CCR7–Notch1 Crosstalk in Mammary Cancer Stemness
2026-11-18
A mouse mammary-tumor study links CCR7 activation to Notch1 cleavage and stem-like cancer-cell behavior. Its results support functional pathway crosstalk, while leaving the direct molecular intermediary, human causality, and therapeutic applicability unresolved.
Context Determines What a Cancer Result Means
2026-11-18
A result’s meaning depends on the model, perturbation, readout, and material context that produced it. The CCR7–Notch1 study illustrates how linked molecular and functional measurements can support a mechanistic interpretation without establishing clinical efficacy or validating an unrelated chromatography product.
How cGMP Signaling May Shape Smooth-Muscle Calcium
2026-11-17
Rp-8-bromo-Cyclic GMPS is described as a competitive inhibitor of cGMP-dependent protein kinase. Its reported effect on calcium accumulation in cultured rat aortic smooth muscle cells provides a mechanistic clue about cGMP-sensitive signaling, but does not by itself establish a direct or clinically relevant pathway effect.
(S)-(+)-Methoprene and Locust JH
2026-11-17
A mechanistic interpretation of how juvenile-hormone abundance, miRNA–mRNA regulation, vitellogenin expression, and ovarian development are connected in migratory locusts, with careful limits on what methoprene pharmacology establishes.
CCR7–Notch1 Crosstalk in Mammary Cancer Stemness
2026-11-16
A mouse mammary-tumor study connected CCR7 signaling with Notch1 cleavage, downstream Hes1 expression, and stem-like behavior. Its evidence supports functional pathway crosstalk in a defined model, while leaving direct molecular coupling, clinical relevance, and applicability to human tumors unresolved.
CCR7–Notch1 Crosstalk and Cancer Stemness
2026-11-16
Evidence from a murine mammary-tumor model supports functional crosstalk between CCR7 and Notch1 in stemness-associated behavior, while leaving the molecular relay and human applicability unresolved. Heparin affinity materials have a distinct analytical role and should not be conflated with evidence for signaling activity.
CCR7–Notch1 Crosstalk in Mammary Cancer Stemness
2026-11-15
Evidence from a genetically defined mouse mammary-tumor model supports a functional link between CCR7 signaling, Notch1 cleavage, and stem-like cancer-cell behavior. The findings suggest pathway dependence, but they do not establish direct molecular binding, clinical causality, or validation of any chromatography product.
When Context Changes a Signaling Result
2026-11-14
A CCR7–Notch1 study in mouse mammary cancer shows why model choice, perturbation type, cellular subpopulation and readout determine what a signaling result can legitimately mean.
CCR7–Notch1 Crosstalk and Stemness Evidence
2026-11-13
A mouse mammary tumor study links CCR7 activity to Notch1 cleavage, downstream HES1 expression, and stem-like cellular behavior. The findings support pathway crosstalk within the MMTV-PyMT model, but leave the intermediate mechanism, clinical relevance, and any relationship to heparin-based biomolecule purification unresolved.
How CCR7 and Notch1 Shape Mammary Tumor Stemness
2026-11-13
Boyle and colleagues used genetic, ligand-based, pharmacologic, and cellular readouts in the MMTV-PyMT mammary tumor model to examine whether CCR7-dependent stem-like behavior is mediated through Notch1. The study supports functional pathway crosstalk, while its mouse-model context, proxy stemness assays, and correlational human analysis limit direct clinical extrapolation.
How CCR7–Notch1 Crosstalk Sustains Tumor Cell Stemness
2026-11-12
A literature-focused analysis of how CCR7 signaling intersects with Notch1 activation in primary MMTV-PyMT mammary cancer cells, what the study’s molecular and functional readouts establish, and where its mouse-model evidence remains limited.
CCR7–Notch1 Crosstalk in Mammary Cancer
2026-11-12
A mechanistic reading of a mouse mammary-cancer study linking CCR7 activation to Notch1 cleavage, Hes1 expression, and stem-like cell behavior, with attention to evidence layers, model boundaries, and translational uncertainty.
CCR7–Notch1 Signaling and Mammary Cancer Stemness
2026-11-11
Evidence from a genetically defined mouse mammary-tumor model links CCR7 activity to Notch1 cleavage, Hes1 expression, and stem-like behavior, while leaving direct molecular binding and clinical relevance unresolved.